Pioglitazone Hydrochloride
Composition :Piozena - 15 Tablet : Each Film Coated Tablet Contains Pioglitazone Hydrochloride USP 15 mg.
Indications :It is indicated as an adjunct to
diet and exercise to improve glycemic control in patients with type Il diabetes
(NIDDM). It also indicated for monotherapy and also indicated for use in
combination with a sulfonylurea, metformin or insulin when diet and exercise
plus the single agent does not result in adequate glycemic control.
Dosage and administration :Pioglitazonen can be taken once
daily without regard to meals. The management of antidiabetic therapy should be
individualized. Pioglitazone monotherapy in patients not adequatelycontrolled
with diet and exercise may beinitiated at 15 mg or 30 mg once daily.
Forpatients who respond inadequately to theinitial dose of pioglitazone,the
dose can beincreased up to 45 mg once daily. Or, asdirected by the registered
physicians.
Use in pregnancy &lactation :Pregnancy-There are no adequate
and well controlledstudies in pregnant women. Pioglitazoneshould be used during
pregnancy only if thepotential benefit justifies the potential risk to the
fetus. Nursing mothers- It is not knownwhether pioglitazone is secreted in
humanmilk. Because many drugs are excreted inhuman milk, it should not be
administered to abreast feeding women.
Packing :Piozena -15 Tablet : Each box contains 28's, tablets in blister pack.